Navigation Links
Clinical Conductor Site Clinical Trial Management System (CTMS) Improves Clinical Trial Productivity at Research Sites
Date:3/25/2009

ROCHESTER, N.Y., March 25 /PRNewswire/ -- Bio-Optronics, Inc., a leader in healthcare workflow software, announces that its Clinical Conductor Site Clinical Trial Management System (CTMS) continues to improve productivity for investigative clinical research sites, particularly in the areas of patient recruitment, advertising ROI, scheduling, and financial management.

Patient recruitment continues to be an area of concern for clinical trials. Clinical Conductor Site CTMS helps improve recruitment efficiency by providing the tools to leverage existing patient databases, easily track advertising ROI, and implement web-based virtual recruitment. At Rochester Clinical Research, "All aspects of recruiting have changed," states Pat Larrabee, President and CEO. "We target and manage our patient population, and are quicker at identifying patients for studies, even difficult ones." She adds, "Clinical Conductor has changed where we put our advertising dollars. We know what's working and what's not." Other sites parallel this experience and some have even gained additional sponsor funding using metrics on the effectiveness of ads.

Clinical Conductor helps sites improve productivity by centralizing information and providing real-time access from multiple locations. At Clinical Research Advantage, scheduling, study status, staffing, and financial management have become more efficient. Eric Levie, Chief Technology Officer states, "We're able to balance staff load better, budget better, and, with real-time data, have an accurate snapshot of the profitability of a study." He adds, "Previously, we used hundreds of spreadsheets, and it took a great deal of time to gather the information needed for payments. Now, stipend payments are issued with a few clicks, and with QuickBooks integration there's no duplicate entry."

Single-site and multi-site clinical research organizations, and those converting from manual spreads
'/>"/>

SOURCE Bio-Optronics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. CareTech Solutions Launches Robust Service Desk Solution to Support Clinical Applications and Technology within Continuum Health Partners Hospitals
2. Intensive summer program helps physicians build clinical research careers
3. Sound Inpatient Physicians Report on New Clinical Processes to Reduce Healthcare Costs and Enhance Care
4. Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes
5. New Clinical Study News for Treatment of Sinusitis, Sinus Infection and Allergy Sufferers Now Have a New Effective Form of Relief through Sinus Dynamics
6. Herbalife Protein Shake Proven Effective in Clinical Study
7. Latest Osteoporosis Research Translated for Health Professionals to Use in Clinical Setting
8. Former Merck Executive Joins Board of Clinical Information Network, Inc.
9. New Clinical Study News for Treatment of Sinusitis - Sinus Infection and Allergy Suffers Now Have a New Effective Form of Relief through Sinus Dynamics
10. Conflicts of interest in clinical research
11. Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... new report on the cigarette brand preferences of middle ... to give the Food and Drug Administration (FDA) the ... Corinne G. Husten, MD, MPH, said today."It,s no accident ... also the favorite brand of high school and middle ...
... The following was released today by Every Child ... vaccines in the debate over the causes of autism. ... (MMR), given in combination with thimerosal-containing vaccines, does not ... major scientific studies which have failed to show a ...
... in Sweden doesn,t transfer to U.S., study finds , , THURSDAY, ... whether smokeless tobacco can help smokers quit cigarettes, contends a ... quit smoking by using snus, a form of moist, powdered ... more popular among male smokers, and Swedish men have higher ...
... Hispanic business and community leaders including the Brooklyn Hispanic ... their strong support for the relicensing of Indian Point ... in Westchester County. , , "Indian ... businesses, schools, and hospitals in New York City rely ...
... NEWARK, N.J., Feb. 12 The Journal of Commerce ... ) will take place May 12 and 13, 2009, ... of the event is "Linking Up the Cold Chain," ... for refrigerated and frozen cargo, will be the conference ...
... February 12 /PRNewswire/,-- , ... for,Cancer Centers , Nucletron, ... Therapy (ART) announced today an exclusive global, strategic,partnership ... high-,dose rate (HDR) brachytherapy afterloader treatment delivery solution ...
Cached Medicine News:Health News:Partnership for Prevention: CDC Report Shows Compelling Need for FDA Regulation of Tobacco 2Health News:Federal Court Declares Vaccines Do Not Cause Autism 2Health News:Smokeless Tobacco May Not Help Smokers Quit 2Health News:Hispanic Leaders Tout Indian Point 2Health News:'Linking Up the Cold Chain' is Focus of The JoC Conferences' First Cool Cargoes Conference, May 12-13, in Portland, Oregon 2Health News:'Linking Up the Cold Chain' is Focus of The JoC Conferences' First Cool Cargoes Conference, May 12-13, in Portland, Oregon 3Health News:Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation 2Health News:Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation 3
(Date:1/14/2014)... 14, 2014  Luminex Corporation (Nasdaq: LMNX ... for the fourth quarter of 2013 on Monday, February ... scheduled for release after the close of trading. ... will hold a conference call to discuss the operating ... twelve months ended December 31, 2013 on February 3, ...
(Date:1/14/2014)... Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s ... a targeting guide with accompanying instrumentation to place and ... adjunct to the soft tissue (e.g. ligament) repair or ... tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ... maintain the anatomical reduction (spacing) of the scaphoid and ...
(Date:1/14/2014)... N.Y. , Jan. 14, 2014   Oligomerix, ... development of disease modifying therapeutics for Alzheimer,s disease ... relocation of its corporate headquarters to ... 2014 and expanded lease agreement for additional laboratory ... Oligomerix, which is focused on the development of ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... HealthCare Pharmaceuticals is pleased to announce it will support the New Jersey ... is the second year in a row that Bayer HealthCare Pharmaceuticals has sponsored the ... , , ... , , ...
... Calif. , July 22 SRI International and the ... Collaborative (the Multidisciplinary Initiative for Surgical Technology Research Advanced Laboratory), in ... $1M grant by the Food and Drug Administration (FDA) ... care. , , ...
Cached Medicine Technology:Bayer HealthCare Pharmaceuticals Supports New Jersey Governor's School in the Sciences at Drew University 2Bayer HealthCare Pharmaceuticals Supports New Jersey Governor's School in the Sciences at Drew University 3SRI International and Stanford University School of Medicine's MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices 2SRI International and Stanford University School of Medicine's MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices 3SRI International and Stanford University School of Medicine's MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices 4SRI International and Stanford University School of Medicine's MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices 5SRI International and Stanford University School of Medicine's MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices 6SRI International and Stanford University School of Medicine's MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices 7
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset...
Latex-enhanced immunoturbidimetric assay for the quantitative in vitro determination of C-reactive protein in serum and plasma...
Medicine Products: